Denali Therapeutics Inc.
FUSION PROTEINS COMPRISING ENZYME REPLACEMENT THERAPY ENZYMES

Last updated:

Abstract:

Provided herein are fusion proteins that comprise an enzyme replacement therapy enzyme and an Fc region, as well as methods of using such proteins to treat a lysosomal storage disorder. Methods for transporting agents across the blood-brain barrier are also provided herein.

Status:
Application
Type:

Utility

Filling date:

23 Nov 2020

Issue date:

1 Jul 2021